Literature DB >> 17294610

Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis--a two-year longitudinal MRI/MRSI study of corpus callosum.

B Audoin1, D Ibarrola, I Malikova, E Soulier, S Confort-Gouny, M V Au Duong, F Reuter, P Viout, A Ali-Chérif, P J Cozzone, J Pelletier, J P Ranjeva.   

Abstract

BACKGROUND: Atrophy of corpus callosum (CC), a white matter structure linking the two hemispheres, is commonly observed in multiple sclerosis (MS). However, the occurrence and processes leading to this alteration are not yet determined. GOAL AND METHODS: To better characterize the onset and progression of CC atrophy from the early stage of MS, we performed a two-year follow-up magnetic resonance imaging/magnetic resonance spectroscopic imaging (MRI/MRSI) exploration of CC in 24 patients with clinically isolated syndrome. These patients were explored using the same protocol at month (M)6, M12 and M24. MRI/MRSI techniques were applied to measure CC volume, and relative concentrations of N-acetylaspartate (NAA), creatine/phosphocreatine (Cr) and choline-containing compounds (Cho). A group of matched controls was also explored.
RESULTS: Atrophy of CC, not present at baseline, was observed at M12 and progressed over the second year (M24). At baseline, a decrease in relative NAA level was observed in the anterior and posterior body of CC, with normalization during the follow-up period. In the anterior body, an increase in relative Cho level was observed, with normalization at M6. Normal relative Cr levels were observed at all time points in all sub-regions. The rate of CC atrophy was correlated with the change in the Expanded Disability Status Scale (EDSS) during the follow-up period.
CONCLUSION: These results suggest that CC atrophy appears over a period of one year after the first acute inflammatory episode, and that this atrophy is accompanied, especially in the anterior body of CC, by a normalization of the relative Cho levels, marker of acute inflammation, and NAA levels, marker of neuronal dysfunction and/or loss.

Entities:  

Mesh:

Year:  2007        PMID: 17294610     DOI: 10.1177/1352458506071215

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  18 in total

1.  Short-term stability of T1 and T2 relaxation measures in multiple sclerosis normal appearing white matter.

Authors:  Alice L W Liang; Irene M Vavasour; Burkhard Mädler; Anthony L Traboulsee; Donna J Lang; David K B Li; Alex L MacKay; Cornelia Laule
Journal:  J Neurol       Date:  2011-11-26       Impact factor: 4.849

2.  Advanced magnetic resonance imaging techniques to better understand multiple sclerosis.

Authors:  Wafaa Zaaraoui; Bertrand Audoin; Jean Pelletier; Patrick J Cozzone; Jean-Philippe Ranjeva
Journal:  Biophys Rev       Date:  2010-04-02

3.  Diffusion tensor MRI as a biomarker in axonal and myelin damage.

Authors:  Wint Yan Aung; Soe Mar; Tammie Ls Benzinger
Journal:  Imaging Med       Date:  2013-10-01

Review 4.  Energy failure in multiple sclerosis and its investigation using MR techniques.

Authors:  David Paling; Xavier Golay; Claudia Wheeler-Kingshott; Raju Kapoor; David Miller
Journal:  J Neurol       Date:  2011-06-10       Impact factor: 4.849

5.  Clinical and cognitive implications of cerebrospinal fluid oligoclonal bands in multiple sclerosis patients.

Authors:  Maria Anagnostouli; Foteini Christidi; Ioannis Zalonis; Chryssoula Nikolaou; Dimitrios Lyrakos; Nikolaos Triantafyllou; Ioannis Evdokimidis; Constantinos Kilidireas
Journal:  Neurol Sci       Date:  2015-07-01       Impact factor: 3.307

6.  Occurrence of neuronal dysfunction during the first 5 years of multiple sclerosis is associated with cognitive deterioration.

Authors:  Wafaa Zaaraoui; Françoise Reuter; Audrey Rico; Anthony Faivre; Lydie Crespy; Irina Malikova; Elisabeth Soulier; Patrick Viout; Yann Le Fur; Sylviane Confort-Gouny; Patrick J Cozzone; Jean Pelletier; Jean-Philippe Ranjeva; Bertrand Audoin
Journal:  J Neurol       Date:  2010-12-04       Impact factor: 4.849

7.  Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy.

Authors:  J Hagemeier; B Weinstock-Guttman; N Bergsland; M Heininen-Brown; E Carl; C Kennedy; C Magnano; D Hojnacki; M G Dwyer; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-29       Impact factor: 3.825

8.  Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis.

Authors:  N Bergsland; D Horakova; M G Dwyer; O Dolezal; Z K Seidl; M Vaneckova; J Krasensky; E Havrdova; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-12       Impact factor: 3.825

9.  Regional white matter atrophy--based classification of multiple sclerosis in cross-sectional and longitudinal data.

Authors:  M P Sampat; A M Berger; B C Healy; P Hildenbrand; J Vass; D S Meier; T Chitnis; H L Weiner; R Bakshi; C R G Guttmann
Journal:  AJNR Am J Neuroradiol       Date:  2009-08-20       Impact factor: 3.825

Review 10.  The prognostic utility of MRI in clinically isolated syndrome: a literature review.

Authors:  C Odenthal; A Coulthard
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-15       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.